Loading organizations...
Loading organizations...
AdaptX: AI-driven software for clinical performance management, analyzing medical data to improve patient care for healthcare providers.
Based in Seattle, Washington, AdaptX develops AI-driven clinical performance management software that analyzes electronic medical record data to help healthcare providers improve patient care and operational efficiency. The enterprise software-as-a-service platform enables medical directors and clinical leaders to monitor treatments, evaluate trends, and manage workflows without requiring specialized IT support. The company operates with an estimated $10 million in annual revenue and maintains a workforce of more than 40 employees. AdaptX has raised over $20 million in total venture capital funding, including a $10 million round backed by investors such as Cercano Management and Innovation Endeavors. Its analytics technology is utilized by various medical institutions, including early adopter Seattle Children's Hospital and strategic investor Memorial Hermann Health System. The organization was originally founded as MDMetrix in 2016 by Dr. Dan Low and Warren Ratliff.
AdaptX has raised $29.0M across 5 funding rounds.
AdaptX has raised $29.0M in total across 5 funding rounds.
AdaptX is a Seattle-based medtech company that builds AI-driven software to help healthcare providers analyze electronic medical record (EMR) data, enabling clinical leaders to manage variation in care across treatments, workflows, and teams.[1][2][6] It addresses critical challenges like capacity constraints, revenue optimization, care quality, health equity, and sustainability by detecting patterns, trends, and inefficiencies in real-world data.[1][2][6] Serving hospitals and health systems such as Seattle Children's Hospital, Memorial Hermann, Children's Minnesota, and Kittitas Valley Healthcare, AdaptX has raised $21.16M in funding (most recently $10M in 2023, led by Cercano Management), employs over 40 people, and operates at Series B stage.[1][2]
The platform's self-serve tools allow clinicians to compare care approaches, identify outcome disparities, and drive improvements without relying on IT teams, fostering energy among surgeons and leaders to align on business goals.[2][6] This has led to demonstrated gains in quality, efficiency, and equity, expanding capacity to serve more patients in diverse settings from academic centers to rural communities.[2][6]
Founded in 2016 as MDmetrix by pediatric anesthesiologist Dr. Dan Low, AdaptX emerged from his real-world challenges at Seattle Children's Hospital, where he struggled to evaluate if a new drug improved outcomes in common surgeries compared to prior methods.[1][2] Low's firsthand experience highlighted the need for accessible data analysis to reduce clinical variation and enhance decision-making, prompting the company's pivot to AI-powered solutions.[2]
Early traction came from proving value in pediatric care, evolving into broader applications for health systems. By 2023, with over 40 employees (doubled from 2021), AdaptX secured $10M in Series B extension funding from investors including Cercano Management, Memorial Hermann, Morningside Ventures, Founders’ Co-Op, Fortson VC, Star Equity, and WRF Capital, fueling platform expansion and customer growth.[1][2]
AdaptX rides the AI in digital health wave, targeting clinical variation management amid rising healthcare costs, staffing shortages, and equity demands—exacerbated by post-pandemic EMR data explosion.[1][2] Timing aligns with health systems' shift to value-based care, where real-world evidence from AI analytics influences reimbursements and regulations like CMS equity mandates.[6]
Market forces favor it: explosive EMR adoption (e.g., Epic, Cerner), AI maturity for healthcare (post-ChatGPT hype), and investor interest in medtech efficiency tools, as seen in $10M raise amid Series B funding.[1][2] AdaptX influences the ecosystem by democratizing data for frontline clinicians, reducing reliance on consultants, and enabling scalable improvements—positioning it in expert collections like Digital Health and AI applications in pediatrics.[1]
AdaptX is poised for accelerated adoption as health systems prioritize AI for operational resilience, with potential expansion into new verticals like maternal health or chronic care via real-time equity insights.[2][6] Trends like multimodal AI integration with wearables/genomics and regulatory pushes for outcome transparency will amplify its edge, while partnerships (e.g., Memorial Hermann) could drive enterprise-scale deployments.[2]
Its influence may evolve from niche pediatric innovator to standard tool in clinical management stacks, especially if it sustains momentum post-2023 funding amid competitive AI health analytics. This builds on its core strength: turning clinician frustration into data-driven wins, much like Dr. Low's original spark at Seattle Children's.
AdaptX has raised $29.0M in total across 5 funding rounds.
AdaptX's investors include YB Choi, Fortson VC, Feby Abraham, Morningside Ventures, Star Equity, WRF Capital, Founders' Co-op, Vulcan Capital, Bukola Ojo, Alumni Ventures, Arnold Venture Group, Brick & Mortar Ventures.
AdaptX has raised $29.0M across 5 funding rounds. Most recently, it raised $10.0M Other Equity in November 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2023 | $10.0M Other Equity | YB Choi | Fortson VC, Feby Abraham, Morningside Ventures, Star Equity, WRF Capital |
| Sep 1, 2023 | $10.0M Series B | Founders' Co-op, Vulcan Capital, Bukola Ojo | |
| Jul 1, 2021 | $6.0M Series A | Vulcan Capital | Founders' Co-op, Bukola Ojo, Alumni Ventures, Arnold Venture Group, WRF Capital |
| May 1, 2019 | $3.0M Seed | Brick & Mortar Ventures, Founders' Co-op, Haystack, Math Capital, Moshe Lifschitz, Arnold Venture Group, WRF Capital | |
| May 1, 2018 | $10K Seed |